{
  "schema_version": 1,
  "content_version": 2,
  "last_updated": "2026-02-17T12:00:00Z",
  "articles": [

    {
      "slug": "bmj-2021-chronic-pain-wang",
      "status": "published",
      "publishedAt": "2021-09-08",
      "title": "Medical Cannabis for Chronic Non-Cancer Pain",
      "subtitle": "Systematic Review & Meta-Analysis (BMJ, 2021)",
      "readingTimeMinutes": 8,

      "image": {
        "remoteURL": "https://YOUR_GITHUB_RAW_URL/assets/med/bmj_pain_2021.webp"
      },

      "category": "schmerz",
      "tags": ["Systematic Review", "Meta-Analysis", "RCT"],
      "cannabinoids": ["thc", "cbd"],
      "disclaimerKey": "medical_general",

      "evidence": {
        "level": "moderat",
        "effectDirection": "mixed",
        "studyTypes": ["systematicReview", "metaAnalysis"],
        "shortStatement": "Small to very small improvements in pain and sleep, with increased short-term adverse events."
      },

      "keyTakeaways": [
        {
          "title": "Effect Size Small",
          "body": "Average improvements are statistically significant but clinically modest.",
          "tone": "info"
        },
        {
          "title": "Side Effects More Common",
          "body": "Sedation, dizziness and GI symptoms were more frequent than placebo.",
          "tone": "warning"
        }
      ],

      "blocks": [
        {
          "id": "b1",
          "type": "paragraph",
          "markdown": "This BMJ meta-analysis evaluated randomized trials of non-inhaled cannabis products for chronic pain. The authors found small improvements in pain and physical functioning compared with placebo."
        }
      ],

      "sources": [
        {
          "id": "s1",
          "type": "metaAnalysis",
          "title": "Medical cannabis or cannabinoids for chronic non-cancer pain",
          "authors": "Wang L, et al.",
          "year": 2021,
          "journalOrPublisher": "BMJ",
          "doi": "10.1136/bmj.n1034",
          "url": "https://www.bmj.com/content/374/bmj.n1034",
          "credibility": "high"
        }
      ]
    },

    {
      "slug": "annals-2022-chronic-pain-mcdonagh",
      "status": "published",
      "publishedAt": "2022-06-07",
      "title": "Cannabis-Based Products for Chronic Pain",
      "subtitle": "Systematic Review (Annals of Internal Medicine, 2022)",
      "readingTimeMinutes": 9,

      "image": {
        "remoteURL": "https://YOUR_GITHUB_RAW_URL/assets/med/annals_pain_2022.webp"
      },

      "category": "schmerz",
      "tags": ["Systematic Review"],
      "cannabinoids": ["thc", "cbd"],
      "disclaimerKey": "medical_general",

      "evidence": {
        "level": "moderat",
        "effectDirection": "mixed",
        "studyTypes": ["systematicReview"],
        "shortStatement": "THC-dominant products show modest benefit but increased adverse events."
      },

      "keyTakeaways": [
        {
          "title": "Product Profile Matters",
          "body": "THC-rich formulations show more effect but also more harms.",
          "tone": "info"
        }
      ],

      "blocks": [
        {
          "id": "b1",
          "type": "paragraph",
          "markdown": "This review categorized cannabis products by THC/CBD ratio and compared clinical outcomes in chronic pain populations."
        }
      ],

      "sources": [
        {
          "id": "s1",
          "type": "review",
          "title": "Cannabis-Based Products for Chronic Pain",
          "authors": "McDonagh MS, et al.",
          "year": 2022,
          "journalOrPublisher": "Annals of Internal Medicine",
          "doi": "10.7326/M21-4520",
          "url": "https://www.acpjournals.org/doi/10.7326/M21-4520",
          "credibility": "high"
        }
      ]
    },

    {
      "slug": "nejm-2017-cbd-dravet-devinsky",
      "status": "published",
      "publishedAt": "2017-05-25",
      "title": "Cannabidiol in Dravet Syndrome",
      "subtitle": "Randomized Controlled Trial (NEJM, 2017)",
      "readingTimeMinutes": 10,

      "image": {
        "remoteURL": "https://YOUR_GITHUB_RAW_URL/assets/med/nejm_cbd_2017.webp"
      },

      "category": "neurologie",
      "tags": ["RCT", "CBD"],
      "cannabinoids": ["cbd"],
      "disclaimerKey": "medical_general",

      "evidence": {
        "level": "stark",
        "effectDirection": "beneficial",
        "studyTypes": ["rct"],
        "shortStatement": "CBD significantly reduced convulsive seizure frequency compared with placebo."
      },

      "keyTakeaways": [
        {
          "title": "High-Level Evidence",
          "body": "Randomized placebo-controlled trial design strengthens conclusions.",
          "tone": "positive"
        }
      ],

      "blocks": [
        {
          "id": "b1",
          "type": "paragraph",
          "markdown": "In this landmark trial, cannabidiol reduced seizure frequency in patients with Dravet syndrome compared with placebo."
        }
      ],

      "sources": [
        {
          "id": "s1",
          "type": "study",
          "title": "Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome",
          "authors": "Devinsky O, et al.",
          "year": 2017,
          "journalOrPublisher": "New England Journal of Medicine",
          "doi": "10.1056/NEJMoa1611618",
          "url": "https://www.nejm.org/doi/full/10.1056/NEJMoa1611618",
          "credibility": "high"
        }
      ]
    },

    {
      "slug": "jama-2015-cannabinoids-medical-use",
      "status": "published",
      "publishedAt": "2015-06-23",
      "title": "Cannabinoids for Medical Use",
      "subtitle": "Systematic Review & Meta-Analysis (JAMA, 2015)",
      "readingTimeMinutes": 9,

      "image": {
        "remoteURL": "https://YOUR_GITHUB_RAW_URL/assets/med/jama_2015.webp"
      },

      "category": "basics",
      "tags": ["Meta-Analysis"],
      "cannabinoids": ["thc", "cbd"],
      "disclaimerKey": "medical_general",

      "evidence": {
        "level": "moderat",
        "effectDirection": "mixed",
        "studyTypes": ["metaAnalysis"],
        "shortStatement": "Moderate-quality evidence for certain indications; short-term adverse events common."
      },

      "keyTakeaways": [
        {
          "title": "Broad Evidence Overview",
          "body": "Assessed multiple indications including pain and spasticity.",
          "tone": "info"
        }
      ],

      "blocks": [
        {
          "id": "b1",
          "type": "paragraph",
          "markdown": "This large meta-analysis evaluated cannabinoids across multiple therapeutic indications and assessed overall benefit-risk profiles."
        }
      ],

      "sources": [
        {
          "id": "s1",
          "type": "metaAnalysis",
          "title": "Cannabinoids for Medical Use: A Systematic Review and Meta-analysis",
          "authors": "Whiting PF, et al.",
          "year": 2015,
          "journalOrPublisher": "JAMA",
          "url": "https://jamanetwork.com/journals/jama/fullarticle/2338251",
          "credibility": "high"
        }
      ]
    },

    {
      "slug": "nasem-2017-health-effects-cannabis",
      "status": "published",
      "publishedAt": "2017-01-12",
      "title": "The Health Effects of Cannabis and Cannabinoids",
      "subtitle": "National Academies Report (2017)",
      "readingTimeMinutes": 11,

      "image": {
        "remoteURL": "https://YOUR_GITHUB_RAW_URL/assets/med/nasem_2017.webp"
      },

      "category": "basics",
      "tags": ["Evidence Report"],
      "cannabinoids": ["thc", "cbd"],
      "disclaimerKey": "medical_general",

      "evidence": {
        "level": "stark",
        "effectDirection": "mixed",
        "studyTypes": ["guideline", "systematicReview"],
        "shortStatement": "Comprehensive evidence review summarizing therapeutic benefits and risks."
      },

      "keyTakeaways": [
        {
          "title": "Best Evidence Overview",
          "body": "Structured evaluation of what is supported by strong vs limited evidence.",
          "tone": "positive"
        }
      ],

      "blocks": [
        {
          "id": "b1",
          "type": "paragraph",
          "markdown": "This landmark report from the National Academies comprehensively reviewed the evidence for therapeutic and adverse health effects of cannabis."
        }
      ],

      "sources": [
        {
          "id": "s1",
          "type": "book",
          "title": "The Health Effects of Cannabis and Cannabinoids",
          "authors": "National Academies of Sciences, Engineering, and Medicine",
          "year": 2017,
          "doi": "10.17226/24625",
          "url": "https://www.nationalacademies.org/publications/24625",
          "credibility": "high"
        }
      ]
    }

  ]
}
